Short-term clinical outcomes of ticagrelor versus clopidogrel after percutaneous coronary intervention in patients with myocardial infarction: A randomized clinical trial study
Background: Reperfusion can be done through primary percutaneous coronary intervention (PPCI) and thrombolytic administration. Patients with myocardial infarction should receive antiplatelet drugs from the P2Y12 receptor inhibitor category (such as ticagrelor, prasugrel, and clopidogrel). Based on r...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Seri Bilgileri: | Research in Cardiovascular Medicine |
| Konular: | |
| Online Erişim: | http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2023;volume=12;issue=2;spage=56;epage=60;aulast=Nikfarjam |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|